Melanoma Posts - Page 18 of 45 on Medivizor
Navigation Menu

Melanoma Posts on Medivizor

5 Things You Probably Didn’t Know About Your Adrenal Glands

5 Things You Probably Didn’t Know About Your Adrenal Glands

Posted by on Mar 15, 2018 in Benign prostatic hyperplasia, Blog, Breast cancer, Colorectal cancer, Coronary artery disease, Diabetes mellitus, Erectile dysfunction, Hodgkin's lymphoma, Hypertension, Infertility, Kidney stones, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer, Rheumatoid Arthritis, Stroke, Urinary incontinence, Urinary tract infection | 5 comments

The adrenal glands-which are also called suprarenal glands-are part of the endocrine system and are found on the top of each kidney. How the endocrine system hormones work Hormones secreted from glands of the endocrine system travel in the bloodstream to target cells. Target cells have receptors that are specific to each hormone. The hormones and receptors...

Read More

Right To Try: Needed Legislation or Snake Oil?

Right To Try: Needed Legislation or Snake Oil?

Posted by on Mar 10, 2018 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 1 comment

Thirty-eight states in the US have passed “Right To Try” laws. These are laws that are created to give terminally ill patients who have run out of options access to experimental drugs that have not completed the FDA approval process.  There is an effort underway to pass this type of legislation on a federal level. On February 8, the #LCSM (Lung...

Read More

Looking for advanced melanoma patients to test the safety and effectiveness of a combined treatment

Looking for advanced melanoma patients to test the safety and effectiveness of a combined treatment

Posted by on Jan 31, 2018 in Melanoma | 0 comments

In a nutshell This phase 2 trial aims to test the safety and effectiveness of the combined treatment with pembrolizumab (Keytruda), trametinib (Mekinist) and dabrafenib (Tafinlar) for advanced melanoma. The main outcomes of this trial include overall survival (time from treatment until death from any cause), side effects and response rate to the...

Read More

To Treat or Not To Treat Cancer: Medical Decision-making

To Treat or Not To Treat Cancer: Medical Decision-making

Posted by on Jan 28, 2018 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 16 comments

Cherry Hughes** is an active, energetic 75 year old, still working in the marketing and public relations profession in Great Britain.  Her life is filled with friends and fun.  “I love cooking and eating out.  I am deeply interested in politics.  I love music …I go to jazz clubs.  I love going to France …I have a little apartment...

Read More

What is Neutropenia?

What is Neutropenia?

Posted by on Jan 21, 2018 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 1 comment

There are 1.6 million people diagnosed with cancer in the US each year. Of these, 650,000 receive chemotherapy. Did you know that 60,000 people a year are hospitalized for neutropenia, a common side effect of chemotherapy? One in fourteen die because of it. Of the 650,000 receiving chemotherapy, 104,000 are not aware of neutropenia and 52,000 don’t...

Read More

Emergencies and Illness

Emergencies and Illness

Posted by on Jan 17, 2018 in Blog, Breast cancer, Colorectal cancer, Coronary artery disease, Diabetes mellitus, Hodgkin's lymphoma, Hypertension, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Prostate cancer | 1 comment

After three hurricanes, flooding, fires and mudslides, and now severe cold and snow in the Deep South and throughout the country, the US has had its share of emergencies. Are you prepared? For people who rely on oxygen, who are on dialysis, have diabetes or other serious conditions, it is time to think about putting together some of the essentials.  What...

Read More

Vemurafenib combined with cobimetinib is an effective treatment option for advanced melanoma

Posted by on Jan 7, 2018 in Melanoma | 0 comments

In a nutshell This study examined the effectiveness of treatment with vemurafenib (Zelboraf) and cobimetinib (Cotellic) in metastatic (spread to other parts of the body) melanoma. Researchers suggested that this combination improves treatment outcomes. Some background PD-L1 is a protein present in the immune system that helps attacking cancer...

Read More